Aernoud Fiolet

Chapter 1 General introduction and thesis outline	11
Chapter 2 Viewing Atherosclerosis through a Crystal Lens: How the Evolving Structure of Cholesterol Crystals in Atherosclerotic Plaque Alters its Stability	51
Chapter 3 Colchicine in Stable Coronary Artery Disease	73
Chapter 4 The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics	93
Chapter 5 Colchicine in Patients with Chronic Coronary Disease	117
Chapter 6 Reply. Colchicine in Patients with Chronic Coronary Disease	161
Chapter 7 The efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomised trials	173
Chapter 8 Colchicine in chronic coronary disease in relation to history of acute coronary syndrome	215
Chapter 9 Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein	233
Chapter 10 Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease. A LoDoCo2 Proteomic Substudy	257
Chapter 11 Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in vitro and in vivo in chronic coronary disease: a LoDoCo2 substudy	267
Chapter 12 Predictors of early intolerance to low-dose colchicine in patients with coronary disease	291
Chapter 13 Text-mining in electronic healthcare records can be used as efficient tool for screening and data collection in cardiovascular trials: a multicenter validation study	313
Chapter 14 Accuracy of using routinely collected electronic healthcare data to identify major cardiovascular endpoints in randomized controlled trials: a multicenter validation study	337
Chapter 15 Clinical implications and future perspectives	359
Chapter 16 Summary	381
Summary in Dutch	391
List of publications	399
Acknowledgements	405
About the author	419

Made with FlippingBook

RkJQdWJsaXNoZXIy ODAyMDc0